Medical Research & Technology

Wilmington, Del. – September 24, 2026 -- Biophysical Therapeutics is now accepting pre-orders for an anti-aging moisturizer priced at $120, with only 500 units available in its first production run at www.IF1.skin.

The Delaware-based biotech company launched the product under a new consumer brand called IF1, named after a protein the company says plays a role in determining lifespan across mammal species.

The moisturizer's formula is based on research into why species age at different rates.

Biophysical Therapeutics says its research found that species with higher levels of IF1 protein tend to live longer -- comparing a mouse's four-year maximum lifespan to a bowhead whale's lifespan of centuries. The company reports that increasing IF1 protein in mice reduced aging as measured by a biomarker for aging.

San Mateo – September 23, 2026 -- A nonprofit that has spent more than three decades helping people navigate life after a breast or ovarian cancer diagnosis is set to be featured on Public Television, with production planned at its San Mateo, California headquarters and aboard its Mobile Resource Center.

Bay Area Cancer Connections will appear in an upcoming episode of "All Access hosted by Andy Garcia," an educational short-form series distributed to Public Television stations nationwide. The organization was founded in 1993 by breast cancer patient Jill Freidenrich and her surgeon, Dr. Ellen Mahoney.

New York – September 20, 2026 -- Mediaplanet has launched its Women vs. Cancer campaign, published Sunday, September 20, within the Los Angeles Times, focusing on symptom awareness, earlier detection and advances in treatment for women's cancers.

Erin Andrews shares her cervical cancer story on the cover

ESPN broadcaster and cervical cancer survivor Erin Andrews serves as the campaign's cover feature, detailing her diagnosis and treatment experience. She emphasizes listening to one's body, keeping up with recommended screenings, and speaking up when something feels wrong.

Shenzhen – September 20, 2026 -- Ping An Healthcare and Technology Company Limited has unveiled "Ping An GlobalCare," a new service designed to help foreign residents in China overcome language barriers and confusing hospital procedures when seeking medical care. The product, revealed at the Shenzhen Sci-Tech Innovation Exhibition, is now available for trial in Shenzhen.

The AI engine translates medical conversations in real time across 19 languages

Ping An GlobalCare uses an AI-powered translation system that supports two-way speech and text conversion, with specific coverage for professional medical terminology. The tool aims to remove communication gaps between international patients and Chinese physicians during consultations.

Users can log in with mobile numbers from 198 countries and regions, a feature intended to make the service accessible to a broad international user base without requiring a local Chinese phone number.

Mountain View – – September 18, 2026 -- Yuvan Research Inc. has introduced NEEL Gel, a skincare product built around GHK-Cu, a copper peptide the company says restores collagen in aging skin rather than temporarily masking wrinkles.

Dr. Michael Snyder says the gel is the only skincare product he uses besides moisturizer

Snyder, Stanford's W. Ascherman Professor of Genetics and director of its Center for Genomics and Personalized Medicine, has used NEEL for more than two years. In a company-produced video, he says small wrinkles "disappeared rather quickly" while larger wrinkles are diminishing more slowly. NEEL's website describes him as looking 25 years younger than his chronological age.

Palo Alto – September 17, 2026 -- Lucile Packard Children's Hospital Stanford tied for the No. 1 spot among children's hospitals in Northern California and ranked No. 2 (tie) statewide, according to the U.S. News & World Report 2026–2027 Best Children's Hospitals survey.

The hospital placed in the national top 5 for two specialties

Neonatology and Nephrology both ranked No. 4 nationally. Four specialties overall landed in the national top 10: Neonatology, Nephrology, Neurology and Neurosurgery (No. 7), and Pulmonology and Lung Surgery (No. 8).

Seattle – September 17, 2026 -- Seattle Children's has secured a spot on U.S. News & World Report's Best Children's Hospitals Honor Roll for the third consecutive year, a recognition given to only 10 hospitals nationwide.

The hospital ranked No. 1 in Washington state and tied for No. 1 in the Pacific region, which covers Alaska, California, Hawaii, Oregon and Washington.

Four specialties crack the national top 10

Seattle Children's ranked in every specialty category evaluated by U.S. News. Four of those specialties -- Cancer, Diabetes & Endocrinology, Nephrology, and Pulmonology & Lung Surgery -- placed among the top 10 in the country.

Baltimore – September 17, 2026 -- Mercy Medical Center has introduced Mako SmartRoboticsTM technology for shoulder replacement surgery, making it among the first providers in the Mid-Atlantic region to offer the robotic-arm assisted procedure.

Orthopedic surgeon Dr. Gregory Gasbarro leads the new program

Gregory V. Gasbarro, M.D., a board-certified orthopedic surgeon and fellowship-trained shoulder specialist at Mercy, is now performing robotic Mako shoulder arthroplasty for patients. He treats patients ages 15 and older through The Shoulder, Elbow, Wrist and Hand Center at Mercy.

The technology builds a 3D surgical plan from a patient's own CT scan

Mako SmartRoboticsTM uses a detailed 3D CT scan of each patient's shoulder to generate a personalized surgical plan. During the operation, the robotic-arm assisted system helps the surgeon execute that plan with added precision while allowing real-time adjustments.

NEW YORK – September 17, 2026 -- A new clinical study finds that a single application of Biodance's Real Deep Hydrogel Mask returned skin to its pre-procedure baseline within hours of fractional laser treatment, a procedure known to temporarily damage the skin's protective barrier.

Researchers tested 32 participants using a split-face design.

Each participant underwent fractional laser treatment, then had the Real Deep Mask applied to one half of the face while the other half remained untreated, allowing direct comparison under identical conditions. Board-certified dermatologists Dr. Luke Maxfield and Dr. Christopher Tomassian presented the results.

Manassas – September 16, 2026 -- Meant Health has expanded its telehealth platform to connect patients with licensed U.S. clinicians for evaluation and prescription of FDA-approved GLP-1 medications, including Ozempic.

Patients start with an intake questionnaire before any prescription decision

The process begins with a questionnaire covering health history, current medications and treatment goals. A licensed clinician then reviews the submission and decides, case by case, whether a prescription is appropriate.

Ozempic is approved for type 2 diabetes, not weight loss

Ozempic carries FDA approval for treating type 2 diabetes. When clinicians prescribe it for weight management, that use is off-label and remains entirely at the clinician's discretion.